Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenotype and Optimal Treatment of Adolescent POI
NCT03568708Phase 3Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Nov 2018
- Primary completion
- Jan 2023
- Countries
- 1
01
Overview
A Phase 3 trial of estradiol topical in primary ovarian insufficiency (POI), sponsored by Cincinnati Children's Hospital Medical Center. Started Nov 2018; status: completed.
02
Drugs
estradiol topical
03
Conditions
primary ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT03568708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03568708.